Wall Street Analysts Believe Nurix Therapeutics (NRIX) Could Rally 29.23%: Here's is How to Trade

Analysts’ mean price target for Nurix Therapeutics (NRIX) implies 29.2% upside. The article notes that this metric alone has not been consistently predictive, but it highlights strong analyst agreement in lifting earnings estimates, suggesting supportive near- to medium-term stock sentiment.

Analysis

Analysts’ mean price target for Nurix Therapeutics (NRIX) implies 29.2% upside. The article notes that this metric alone has not been consistently predictive, but it highlights strong analyst agreement in lifting earnings estimates, suggesting supportive near- to medium-term stock sentiment.